Skip to main content

CITADEL ADVISORS LLC

Position in DFTX — Definium Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in DFTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$79,431,131
+$54,229,078 QoQ
Shares Held
1,688,587
+26.6% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 358 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Derivatives in DFTX

reported options exposure · as of Jun 30, 2026
CallValue
$13,547,520
CallShares
288,000
PutValue
$13,382,880
PutShares
284,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. DFTX ranks #18 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DFTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,382,880 284,500
2026-06-30 $13,547,520 288,000
2026-06-30 $79,431,131 1,688,587
2026-03-31 $1,619,730 85,700
2026-03-31 $1,324,890 70,100
2026-03-31 $25,202,053 1,333,442